Invivyd, Inc. (IVVD)
2.32
-0.06
(-2.52%)
USD |
NASDAQ |
Dec 12, 16:00
2.32
0.00 (0.00%)
After-Hours: 19:12
Invivyd EPS Diluted (Quarterly): -0.0615 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cidara Therapeutics, Inc. | -3.096 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Absci Corp. | -0.1997 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.47M |
| Revenue (Quarterly) | 13.13M |
| Total Expenses (Quarterly) | 23.60M |
| Enterprise Value | 472.54M |
| Gross Profit Margin (Quarterly) | 88.43% |
| Profit Margin (Quarterly) | -79.75% |
| Earnings Yield | -20.41% |
| Normalized Earnings Yield | -20.41 |